Cite
Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone.
MLA
Fiellin, David A., et al. “Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 56, Mar. 2011, pp. S33–38. EBSCOhost, https://doi.org/10.1097/QAI.0b013e3182097537.
APA
Fiellin, D. A., Weiss, L., Botsko, M., Egan, J. E., Altice, F. L., Bazerman, L. B., Chaudhry, A., Cunningham, C. O., Gourevitch, M. N., Lum, P. J., Sullivan, L. E., Schottenfeld, R. S., & O’Connor, P. G. (2011). Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 56, S33–S38. https://doi.org/10.1097/QAI.0b013e3182097537
Chicago
Fiellin, David A, Linda Weiss, Michael Botsko, James E Egan, Frederick L Altice, Lauri B Bazerman, Amina Chaudhry, et al. 2011. “Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 56 (March): S33–38. doi:10.1097/QAI.0b013e3182097537.